Partial Oral Antibiotic Treatment for Bacterial Brain Abscess

PHASE4RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 6, 2020

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions
Brain AbscessCerebral Abscess
Interventions
DRUG

Early transition to oral antibiotics

Patients will be treated with an oral antibiotic regimen (e.g. amoxicillin + metronidazole) based upon pharmacokinetic and pharmacodynamic properties of the drugs, pathogen susceptibility, and any existing drug allergies or interactions

DRUG

Standard treatment of intravenous antibiotics

Patients will continue standard intravenous antibiotic therapy for brain abscess (e.g. 3rd generation cephalosporin + metronidazole) according to international guidelines and pathogen susceptibility patterns.

Trial Locations (4)

Unknown

RECRUITING

Aalborg University Hospital, Aalborg

RECRUITING

Aarhus University Hospital, Aarhus

RECRUITING

Rigshospitalet, Copenhagen

RECRUITING

Odense University Hospital, Odense

All Listed Sponsors
lead

Henrik Nielsen

OTHER